NCT00133237View on ClinicalTrials.gov

Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

PHASE4CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Coronary Disease
Interventions
DEVICE

Sirolimus-eluting stent

cypher stent is implanted due to randomization.

DEVICE

Paclitaxel-eluting stent

taxus stent is implanted due to randomization.

Trial Locations (2)

80636

Deutsches Herzzentrum, Munich

81675

First Medizinische Klinik, Klinikum rechts der Isar, Munich

All Listed Sponsors
collaborator

Technical University of Munich

OTHER

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00133237 - Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN) | Biotech Hunter | Biotech Hunter